Acute toxicity and prothrombotic effects of Quantum dots: Impact of surface charge

Environmental Health Perspectives

Volumn 116, Issue 12, 2008, Pages 1607-1613

  Geys, Jorina ^a   Nemmar, Abderrahim ^a,b   Verbeken, Erik ^c   Smolders, Erik ^a   Ratoi, Monica ^d   Hoylaerts, Marc F ^e   Nemery, Benoit ^a   Hoet, Peter H M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Blood cell analysis; Coagulation; In vivo; Intravenous; Nanoparticles; Platelet aggregation; Quantum dots; Surface charge; Thrombosis; Toxicity

Indexed keywords

ADENOSINE DIPHOSPHATE; AMINE; CADMIUM; HEPARIN; PADGEM PROTEIN; QUANTUM DOT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIGHT SCATTERING; LUNG CIRCULATION; LUNG LAVAGE; LUNG TOXICITY; MALE; MATERIAL COATING; MOUSE; NANOTOXICOLOGY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SURFACE CHARGE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOSIS; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BAGG ALBINO MOUSE; HUMAN; PARTICLE SIZE; SURFACE PROPERTY;

ANIMALIA; MURINAE; MUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; PLATELET AGGREGATION; QUANTUM DOTS; SURFACE PROPERTIES; THROMBOSIS; TISSUE DISTRIBUTION;

EID: 58149340533     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11566     Document Type: Article

References (32)

1. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99:12617-12621.
2. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Nonivasive imaging of quantum dots in mice. Bioconjugate Chem 15:79-86.
3. Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 4:11-18.
4. Fischer H, Liu L, Pang KS, Chan WCW. 2006. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater 16:1299-1305.
5. Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, et al. 2001. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 98:85-92.
6. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969-976.
7. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, Warbritton AR, et al. 2007. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98:249-257.
8. Hardman R. 2006. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 114:165-172.
9. Hoet PHM, Nemmar A, Nemery B. 2004. Health impact of nanomaterials? [Letter]. Nat Biotechnol 22:19.
10. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. 2003. Longterm multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol 21:47-51.
11. Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng YW, Cheng A, et al. 2003. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 102:3224-3231.
12. Kim S, Lim YT, Soltesz EG, De Grand AM, Lee J, Nakayama A, et al. 2004. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93-97.
13. Kirchner C, Liedl T, Kudera S, Pellegrino T, Munoz JA, Gaub HE, et al. 2005. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 5:331-338.
14. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, et al. 2003. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300:1434-1436.
15. Lovric J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. 2005a. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377-385.
16. Lovric J, Cho SJ, Winnik FM, Maysinger D. 2005b. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 12:1227-1234.
17. Maynard AD. 2006. Safe handling of nanotechnology. Nature 444:267-269.
18. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. 2005. Quantum dot bioconjugates for imaging, labeling and sensing. Nat Mater 4:435-446.
19. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al. 2005. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307:538-544.
20. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, et al. 2002. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 166:998-1004.
21. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8; doi:10.1186/1743-8977-2-8 [Online 6 October 2005].
22. Oberdörster G, Oberdörster E, Oberdörster J. 2005b. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
23. Oury C, Kuijpers MJ, Toth-Zsamboki E, Bonnefoy A, Danloy S, Vreys I, et al. 2003. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 101:3969-3976.
24. Shiohara A, Hoshino A, Hanaki K-I, Suzuki K, Yamamoto K. 2004. On the cytotoxicity caused by quantum dots. Microbiol Immunol 48:669-675.
25. So MK, Xu C, Loening AM, Gambhir SS, Rao J. 2006. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol 24:339-343.
26. Soo Choi H, Liu W, Misra P, Tanaka E, Zimmer JP, Itty IB, et al. 2007. Renal clearance of quantum dots. Nat Biotechnol 25:1165-1170.
27. Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, et al. 2005. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 11:678-682.
28. Tada H, Higuchi H, Wanatabe TM, Ohuchi N. 2007. In vivo realtime tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res 67:1138-1144.
29. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794-1807.
30. Yang RSH, Chang LW, Wu J-P, Tsai M-H, Wang H-J, Kuo Y-C, et al. 2007. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect 115:1339-1343.
31. Yu X, Chen L, Li K, Li Y, Xiao S, Luo X, et al. 2007. Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J Biomed Opt 12:014008.
32. Zhu M-Q, Chang E, Sun J, Drezek RA. 2007. Surface modification and functionalization of semiconductor quantum dots through reactive coating of silanes in toluene. J Mater Chem 17:800-805.